Back to Search
Start Over
Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial
- Source :
- The Lancet; January 2023, Vol. 401 Issue: 10372 p195-203, 9p
- Publication Year :
- 2023
-
Abstract
- S-1 has shown promising efficacy with a mild toxicity profile in patients with advanced biliary tract cancer. The aim of this study was to evaluate whether adjuvant S-1 improved overall survival compared with observation for resected biliary tract cancer.
Details
- Language :
- English
- ISSN :
- 01406736 and 1474547X
- Volume :
- 401
- Issue :
- 10372
- Database :
- Supplemental Index
- Journal :
- The Lancet
- Publication Type :
- Periodical
- Accession number :
- ejs61712328
- Full Text :
- https://doi.org/10.1016/S0140-6736(22)02038-4